Accellent begins tender offers for 8 3/8% notes, 10% subordinated notes

By Angela McDaniels

Tacoma, Wash., Feb. 11 - Accellent Inc. began tender offers for its $400 million 8 3/8% senior secured notes due 2017 and $315 million 10% senior subordinated notes due 2017, according to a company news release.

The early tender date is 5 p.m. ET on Feb. 25, and each offer will end at 11:59 p.m. ET on March 11.

For each $1,000 principal amount of notes, the full tender offer consideration is $1,044.19 for the 8 3/8% notes and $1,081.00 for the 10% notes. These payments includes a $30.00 early tender payment for each $1,000 principal amount of notes tendered by the early tender date.

The company will also pay accrued interest up to but excluding the settlement date.

The full tender offer consideration for the 8 3/8% notes was determined with consideration given to the company's right to redeem up to $40 million of the 8 3/8% notes at 103% of par and the remaining 8 3/8% notes at 104.188% of par.

The full tender offer consideration for the 10% notes was determined with consideration given to the company's right to redeem the 10% notes at 107.5% of par.

The company expects to redeem any notes that remain outstanding after the consummation of the offers, and it expects the redemption prices to be less than the full tender offer considerations.

Accellent may choose to accept for purchase notes tendered by the early tender date and settle them prior to the expiration date.

The tender offers are conditioned on the completion of the company's acquisition of Lake Region Medical Holdings, Inc. and the receipt of $1.13 billion of financing, which will be used to complete the merger and to refinance the notes and the company's existing credit facilities.

The dealer managers are Goldman Sachs & Co. (800 828 3182 or 212 357-0215) and UBS Securities LLC (888 719-4210 or 203 719-4210). The depositary and information agent is Global Bondholder Services Corp. (866 807-2200 or, for banks and brokers, 212 430-3774).

Accellent provides outsourced manufacturing and engineering services to the medical device industry and is based in Wilmington, Mass.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.